An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...
Tag: CRISPR Therapeutics
Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success
Text size Intellia CEO John Leonard called the results a vindication of the company’s modular approach to Crispr therapies. Courtesy Intellia Therapeutics Patients who got a one-time gene-editin...
Roku, Tesla, and Other Cathie Wood Favorites Are Falling
Text size Ark Invest CEO Cathie Wood. Courtesy of ARK Cathie Wood’s $12 billion flagship exchange-traded fund was falling again in Monday trading. It is another sign that “innovation stocks” such as R...
Stocks Are on a Wild Ride. 20 Bargains to Buy Now, According to Barron’s Roundtable Experts.
Fed be nimble, Fed be quick. The quicker, the better, in fact. Hike interest rates, shrink your balance sheet, and let’s be done with it all before the stock market sinks even further. The market’s re...